Chapter title |
The Future of CRISPR Applications in the Lab, the Clinic and Society
|
---|---|
Chapter number | 9 |
Book title |
Precision Medicine, CRISPR, and Genome Engineering
|
Published in |
Advances in experimental medicine and biology, January 2017
|
DOI | 10.1007/978-3-319-63904-8_9 |
Pubmed ID | |
Book ISBNs |
978-3-31-963903-1, 978-3-31-963904-8
|
Authors |
Soren H. Hough, Ayokunmi Ajetunmobi, Hough, Soren H., Ajetunmobi, Ayokunmi |
Abstract |
CRISPR (clustered regularly interspaced short palindromic repeats) has emerged as one of the premiere biological tools of the century. Even more so than older genome editing techniques such as TALENs and ZFNs, CRISPR provides speed and ease-of-use heretofore unheard of in agriculture, the environment and human health. The ability to map the function of virtually every component of the genome in a scalable, multiplexed manner is unprecedented. Once those regions have been explored, CRISPR also presents an opportunity to take advantage of endogenous cellular repair pathways to change and precisely edit the genome [1-3]. In the case of human health, CRISPR operates as both a tool of discovery and a solution to fundamental problems behind disease and undesirable mutations. |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 1 | 100% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 1 | 100% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 80 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Bachelor | 18 | 23% |
Researcher | 11 | 14% |
Student > Ph. D. Student | 11 | 14% |
Student > Master | 10 | 13% |
Other | 7 | 9% |
Other | 8 | 10% |
Unknown | 15 | 19% |
Readers by discipline | Count | As % |
---|---|---|
Biochemistry, Genetics and Molecular Biology | 22 | 28% |
Agricultural and Biological Sciences | 14 | 18% |
Engineering | 7 | 9% |
Neuroscience | 3 | 4% |
Medicine and Dentistry | 3 | 4% |
Other | 12 | 15% |
Unknown | 19 | 24% |